World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
24790
World Ranking
3873
National Ranking
1921

Elizabeth A. Grimm publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Elizabeth A. Grimm sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 329 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Elizabeth A. Grimm D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Elizabeth A. Grimm sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 81 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Elizabeth A. Grimm is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple interconnected fields focusing primarily on medicine, biochemistry, genetics, and molecular biology, with significant work in oncology, immunology, molecular biology, cellular and molecular neuroscience, and ophthalmology.

The scientist has contributed to a body of knowledge that includes diverse topics such as macrophage migration inhibitory factor, nuclear receptors and signaling, nanoplatforms for cancer theranostics, peptidase inhibition and analysis, nitric oxide and endothelin effects, ocular oncology and treatments, and CAR-T cell therapy research.

Frequent collaborators in their research include Jason Roszik, Dai Ogata, Yong Qin, Sühendan Ekmekçioğlu, and Matías A. Bustos.

The common venues where their work is published reflect their research focus and include Cancer Research, Cell Death and Disease, Blood, Cancers, and bioRxiv (Cold Spring Harbor Laboratory).

Notable recent publications include:

  • Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma (2022), published in Cell Death and Disease
  • iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation (2021), published in Frontiers in Oncology
  • A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma (CNSL) (2022), published in Blood
  • Multi-modal molecular programs regulate melanoma cell state (2022), published in Nature Communications
  • Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth (2022), published in Cancers

Elizabeth A. Grimm's research includes a focus on tumor biology, immune response modulation, signaling pathways involved in cancer progression, and innovative therapeutic approaches such as CAR-T cell therapy. Their work contributes important insights into melanoma and lymphoma as well as ocular oncology.

They have been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2012.

Best Publications

  • Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

    Elizabeth A Grimm;A. Mazumder;H. Z. Zhang;S. A. Rosenberg

  • Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

    A. Gordon Robertson;Juliann Shih;Juliann Shih;Christina Yau;Ewan A. Gibb

  • Biological activity of recombinant human interleukin-2 produced in Escherichia coli

    Steven A. Rosenberg;Elizabeth A. Grimm;Michael Mcgrogan;Michael Doyle

  • Lysis of Fresh and Cultured Autologous Tumor by Human Lymphocytes Cultured in T-Cell Growth Factor

    Michael T. Lotze;Elizabeth A. Grimm;Amitabha Mazumder;John L. Strausser

  • Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene

    Toshiyoshi Fujiwara;Elizabeth A. Grimm;Tapas Mukhopadhyay;Wei Wei Zhang

  • Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

    Elizabeth Ann Grimm;Keith M. Ramsey;Amitabha Mazumder;Debra J. Wilson

  • The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses

    S. Farzana Hussain;David Yang;Dima Suki;Kenneth Aldape

  • DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.

    Laurie B. Owen-Schaub;Shin Yonehara;William L. Crump;Elizabeth A. Grimm

  • The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-24

    Eva G. Caudell;John B. Mumm;Nancy Poindexter;Suhendan Ekmekcioglu

  • Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.

    Elizabeth A Grimm;R. J. Robb;Jack A Roth;L. M. Neckers

  • Uveal Melanoma: From Diagnosis to Treatment and the Science in Between

    Chandrani Chattopadhyay;Dae Won Kim;Dan S. Gombos;Junna Oba

  • Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma

    Jahan S. Khalili;Shujuan Liu;Tania G. Rodríguez-Cruz;Mayra Whittington

  • Anvendelse av villtype p53-protein eller p53-kodende sekvens for fremstilling av et medikament for behandling av kreft.

    Zhang Wei-Wei;Roth Jack A;Fujiwara Toshiyoshi;Grimm Elizabeth A

  • Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.

    Elizabeth Grimm;Benjamin Bonavida

  • A Retroviral Wild-type p53 Expression Vector Penetrates Human Lung Cancer Spheroids and Inhibits Growth by Inducing Apoptosis

    Toshiyoshi Fujiwara;Elizabeth A. Grimm;Tapas Mukhopadhyay;De Wei Cai

  • Therapeutic Effect of a Retroviral Wild-Type p53 Expression Vector in an Orthotopic Lung Cancer Model

    Toshiyoshi Fujiwara;De Wei Cai;Renee N. Georges;Tapas Mukhopadhyay

  • The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

    Mitsuru Tsudo;Carolyn K. Goldman;Kathleen F. Bongiovanni;Wing C. Chan

  • Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

    Julie A. Ellerhorst;Victoria R. Greene;Suhendan Ekmekcioglu;Carla L. Warneke

  • Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer Patients

    Alex W. Tong;John Nemunaitis;Dan Su;Yuan Zhang

  • Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma (vol 32, pg 204, 2017)

    A.G. Robertson;J.L. Shih;C. Yau;E.A. Gibb

Frequent Co-Authors

Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Jason Roszik
Jason Roszik The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Victor G. Prieto
Victor G. Prieto The University of Texas MD Anderson Cancer Center
Toshiyoshi Fujiwara
Toshiyoshi Fujiwara Okayama University
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Qingyi Wei
Qingyi Wei Duke University
Sunil Chada
Sunil Chada The University of Texas MD Anderson Cancer Center
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Rajagopal Ramesh
Rajagopal Ramesh University of Oklahoma Health Sciences Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Elizabeth A. Grimm

Trending Scientists

Recently Published Articles